Breaking News Instant updates and real-time market news.

AMGN

Amgen

$167.24

-0.31 (-0.19%)

16:12
10/05/16
10/05
16:12
10/05/16
16:12

Amgen to present new data on IMLYGIC, Vectibix at ESMO

Amgen announced that new data on IMLYGIC in combination with an immune checkpoint inhibitor and results from retrospective analyses on Vectibix will be presented at the European Society for Medical Oncology 2016 Congress, Oct. 7-11, 2016, in Copenhagen. IMLYGIC presentations include interim results from a Phase 2 trial evaluating IMLYGIC in combination with ipilimumab versus ipilimumab alone in patients with unresected stage IIIB-IV melanoma. Vectibix abstracts include retrospective analyses of the first-line Phase 3 PRIME and PEAK studies, evaluating the association between tumor site of origin and treatment efficacy in patients with RAS wild-type metastatic colorectal cancer.

  • 07

    Oct

  • 07

    Oct

  • 05

    Nov

  • 06

    Nov

  • 19

    Jul

AMGN Amgen
$167.24

-0.31 (-0.19%)

09/01/16
09/01/16
NO CHANGE

Amgen's sBLA for Blincyto approved by FDA
Amgen's supplemental Biologics License Application for Blincyto has been approved by the FDA to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. This indication is approved under accelerated approval, and continued approval may be contingent upon verification of clinical benefit in subsequent trials. The approval is based on results from the Phase 1/2 '205, an open-label, multicenter, single-arm trial, which evaluated the efficacy and safety of BLINCYTO in pediatric patients with relapsed or refractory B-cell precursor ALL. Blincyto was granted breakthrough therapy, priority review and orphan drug designations by FDA, and is now approved in the U.S. for the treatment of Ph- relapsed or refractory B-cell precursor ALL. In November 2015, BLINCYTO was granted conditional marketing authorization in the European Union for the treatment of adults with Ph- relapsed or refractory B-cell precursor ALL.
09/27/16
GSCO
09/27/16
NO CHANGE
Target $206
GSCO
Conviction Buy
Goldman surprised by Amgen's Kyprolis outcome in first-line multiple myeloma
Last night, Amgen announced Phase 3 Kypolis CLARION study did not meet the primary endpoint in first-line multiple myeloma. Goldman analyst Terence Flynn was surprised by this outcome given the prior positive superiority data for Kyprolis versus Velcade in the Phase III ENDEAVOR trial. Flynn sees risk to his Kyprolis $1B sales estimate in a first-line setting, but awaits for additional details from the call and further information regarding another ongoing Phase III trial. He expects Amgen shares to be weak on the news but said the company has additional drivers beyond Kyprolis including Repatha for high cholesterol and Erenumab for migraine with additional data expected in 2H 2016 and Q1 2017. Flynn remains Conviction Buy rated on Amgen and maintains his $206 price target.
09/27/16
PIPR
09/27/16
NO CHANGE
PIPR
Overweight
Amgen's Kyprolis in good shape despite trial miss, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Amgen's Kyprolis is still likely to be viewed as a "potent backbone, with the right drugs" after a Phase 3 study in front-line myeloma failed to reach its primary endpoint. The analyst believes the impact of the failed trial on Kyprolis use will be limited and he reiterates an Overweight rating on Amgen.
09/29/16
PIPR
09/29/16
NO CHANGE
Target $10
PIPR
Overweight
Arrowhead price target raised to $10 from $8 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Arrowhead Pharmaceuticals (ARWR) to $10 after the company licensed two preclinical cardiovascular RNAi drugs with Amgen (AMGN). Amgen is the "ideal partner" and Arrowhead's balance sheet is now "meaningfully" strengthened, Tenthoff tells investors in a research note. He reiterates an Overweight rating on Arrowhead.

TODAY'S FREE FLY STORIES

KDMN

Kadmon

$3.72

0.34 (10.06%)

18:20
06/26/17
06/26
18:20
06/26/17
18:20
Hot Stocks
Breaking Hot Stocks news story on Kadmon »

Goldentree Asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$155.23

1.12 (0.73%)

, DB

Deutsche Bank

$16.88

0.24 (1.44%)

18:05
06/26/17
06/26
18:05
06/26/17
18:05
Hot Stocks
IBM selected by Digital Trade Chain Consortium to build blockchain platform »

IBM (IBM) announced that…

IBM

IBM

$155.23

1.12 (0.73%)

DB

Deutsche Bank

$16.88

0.24 (1.44%)

HSBC

HSBC

$43.91

0.55 (1.27%)

NTXFF

Natixis

$6.68

0.09 (1.37%)

SCGLY

Societe Generale

$10.39

0.095 (0.92%)

UNCFF

UniCredit

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

CE

Celanese

$93.76

0.2 (0.21%)

18:02
06/26/17
06/26
18:02
06/26/17
18:02
Hot Stocks
Celanese announces Plasticizer WVC 3800 price increases in Europe, Asia »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$29.19

0.75 (2.64%)

18:00
06/26/17
06/26
18:00
06/26/17
18:00
Hot Stocks
NAVER to acquire Xerox Research Centre Europe »

NAVER Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESES

Eco-Stim Energy

$1.12

0.01 (0.90%)

17:59
06/26/17
06/26
17:59
06/26/17
17:59
Earnings
Eco-Stim Energy sees Q2 revenue $8.4M-$9.6M, consensus $7.47M »

Eco-Stim Energy Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$145.82

-0.46 (-0.31%)

17:58
06/26/17
06/26
17:58
06/26/17
17:58
Periodicals
Apple likely acquired eye tracking company SensoMotoric, MacRumors says »

Apple appears to have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NRIM

Northrim BanCorp

$30.35

-0.1 (-0.33%)

17:58
06/26/17
06/26
17:58
06/26/17
17:58
Hot Stocks
Northrim promotes Joe Schierhorn to president and CEO »

Northrim BanCorp Inc.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$24.01

-1.53 (-5.99%)

17:49
06/26/17
06/26
17:49
06/26/17
17:49
Hot Stocks
Arconic issues statement on Reynobond PE »

Arconic issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$8.92

0.39 (4.57%)

, AGO

Assured Guaranty

$41.55

0.9 (2.21%)

17:37
06/26/17
06/26
17:37
06/26/17
17:37
Hot Stocks
MBIA jumps after analyst sees debt ratings adding sale pressure »

Shares of MBIA Inc (MBI)…

MBI

MBIA

$8.92

0.39 (4.57%)

AGO

Assured Guaranty

$41.55

0.9 (2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESPR

Esperion

$42.87

-1.47 (-3.32%)

, JCP

J.C. Penney

$4.67

0.11 (2.41%)

17:35
06/26/17
06/26
17:35
06/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Esperion (ESPR),…

ESPR

Esperion

$42.87

-1.47 (-3.32%)

JCP

J.C. Penney

$4.67

0.11 (2.41%)

FNJN

Finjan Holdings

$3.62

-0.18 (-4.74%)

NEOS

Neos Therapeutics

$7.35

0.1 (1.38%)

WDC

Western Digital

$92.66

-0.68 (-0.73%)

STX

Seagate

$42.39

-0.28 (-0.66%)

BLUE

bluebird bio

$111.10

-0.9 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

JCP

J.C. Penney

$4.67

0.11 (2.41%)

17:31
06/26/17
06/26
17:31
06/26/17
17:31
Upgrade
J.C. Penney rating change  »

J.C. Penney upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$149.70

0.85 (0.57%)

17:31
06/26/17
06/26
17:31
06/26/17
17:31
Hot Stocks
Valmont names Stephen Kaniewski CEO effective December 31, 2017 »

Valmont Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGZ

Vista Gold

$0.87

0.02 (2.35%)

17:29
06/26/17
06/26
17:29
06/26/17
17:29
Syndicate
Breaking Syndicate news story on Vista Gold »

Vista Gold files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRVG

trivago

$20.55

-0.31 (-1.49%)

17:26
06/26/17
06/26
17:26
06/26/17
17:26
Hot Stocks
Breaking Hot Stocks news story on trivago »

Steadfast Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSA

National Storage

$22.63

0.22 (0.98%)

, BLKB

Blackbaud

$89.25

-0.25 (-0.28%)

17:18
06/26/17
06/26
17:18
06/26/17
17:18
Hot Stocks
Breaking Hot Stocks news story on National Storage, Blackbaud »

National Storage to…

NSA

National Storage

$22.63

0.22 (0.98%)

BLKB

Blackbaud

$89.25

-0.25 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLKB

Blackbaud

$89.25

-0.25 (-0.28%)

, CST

CST Brands

$48.54

0.18 (0.37%)

17:17
06/26/17
06/26
17:17
06/26/17
17:17
Hot Stocks
Blackbaud to replace CST Brands in S&P 400 at open on 6/29 »

Alimentation Couche-Tard…

BLKB

Blackbaud

$89.25

-0.25 (-0.28%)

CST

CST Brands

$48.54

0.18 (0.37%)

ANCUF

Alimentation Couche-Tard

$48.08

1.9887 (4.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATY

Cathay General

$36.99

0.08 (0.22%)

17:13
06/26/17
06/26
17:13
06/26/17
17:13
Hot Stocks
Cathay General extends 'end date' for SinoPac acquisition »

Cathay General Bancorp,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGEN

Repligen

$45.34

1.14 (2.58%)

17:13
06/26/17
06/26
17:13
06/26/17
17:13
Syndicate
Repligen files to sell $100M of common stock »

J.P. Morgan Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHF

WhiteHorse Finance

$14.37

-0.09 (-0.62%)

17:10
06/26/17
06/26
17:10
06/26/17
17:10
Syndicate
WhiteHorse Finance files to sell 2.5M shares of common stock »

Deutsche Bank Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OZRK

Bank of the Ozarks

$46.08

0.64 (1.41%)

17:07
06/26/17
06/26
17:07
06/26/17
17:07
Hot Stocks
Bank of the Ozarks completes internal reorganization »

Bank of the Ozarks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

SRSC

Sears Canada

$0.35

-0.01 (-2.78%)

17:06
06/26/17
06/26
17:06
06/26/17
17:06
Hot Stocks
Sears Canada common shares to be delisted from Nasdaq »

Sears Canada received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTE

Baytex Energy

$2.27

0.05 (2.25%)

17:03
06/26/17
06/26
17:03
06/26/17
17:03
Hot Stocks
Baytex Energy estimates Q2 averate production at 72,500 boe/d, up 5% »

Baytex Energy provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKJ

Bancorp of New Jersey

$16.55

0.05 (0.30%)

17:02
06/26/17
06/26
17:02
06/26/17
17:02
Hot Stocks
Bancorp of New Jersey announces 5% stock dividend »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARR

ARMOUR Residential

$27.48

0.17 (0.62%)

17:00
06/26/17
06/26
17:00
06/26/17
17:00
Syndicate
ARMOUR Residential files to sell 4.5M shares of common stock »

Morgan Stanley & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKS

AK Steel

$6.54

-0.11 (-1.65%)

16:57
06/26/17
06/26
16:57
06/26/17
16:57
Hot Stocks
Breaking Hot Stocks news story on AK Steel »

Integrated Core…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.